Trump promised cheaper drugs. Some prices dropped. Many others shot up.

Key Points:

• Since his second term began, President Trump has launched multiple initiatives aimed at reducing prescription drug prices, including demanding voluntary price cuts from drugmakers and introducing the TrumpRx website for discounted medicines.
• Despite these efforts, many details remain unclear, and experts criticize the deals as largely symbolic and unenforceable, with limited impact on overall drug pricing.
• The most significant price reductions have come from the continuation of Medicare drug price negotiations initiated under the Biden administration, expected to save Medicare over $20 billion annually.
• TrumpRx primarily offers discounts on brand-name drugs to uninsured patients paying cash, but many discounted prices remain higher than generic alternatives available through other programs.
• Some notable discounts include fertility drugs and weight loss medications, though patent protections and market exclusivity continue to limit broader access to cheaper generics and biosimilars in the U.S. market.